Articles

  • Dec 4, 2024 | asbmb.org | Anna Hu

    In 2019, Vincent Tagliabracci received an email from a French bioinformatician alerting him to a similarity between part of the replication complex of the SARS coronavirus –– which had caused an outbreak in the early 2000s –– and a protein Tagliabracci had been working on. Tagliabracci, an associate professor in the molecular biology department at the University of Texas Southwestern, wrote back that he wasn’t interested in working on coronaviruses. Then, 2020 came.

  • Nov 27, 2024 | archermagazine.com.au | Anna Hu

    For five years, the Queer/Trans Zine Fest, hosted outdoors in Providence, Rhode Island, USA, provided a space to boldly celebrate queer art and artists. This year was the last iteration of the beloved festival, which hosted thousands of attendees and over 70 exhibitors across the free, six-hour event. The festival was dreamed up by nine friends in 2017 and it expanded with each run, experiencing a resurgence in interest after a several-year hiatus around the height of COVID-19.

  • Nov 7, 2024 | asbmb.org | Anna Hu

    Five years into graduate school, Crystal Mendoza thought she had it all figured out. She’d been the first in her family to attend college, completed the applications on her own, moved away and battled homesickness. Finally, she was established in a lab and studying the science she loved. Physically, however, she was struggling. At the age of 24, she was experiencing mental fog and mysterious, debilitating pain that made it impossible to work at the bench.

  • Oct 9, 2024 | asbmb.org | Anna Hu

    On a resume, Shane Austin’s scientific path looks remarkably straightforward. He started with a double major undergraduate degree in biochemistry and chemistry, moved directly to a research master’s degree, completed his Ph.D. in five years, and landed an academic position at his undergraduate alma mater. On a map though, Austin’s path traces a giant triangle that spans the Atlantic Ocean.

  • May 14, 2024 | uspharmacist.com | Anna Hu

    US Pharm. 2024;49(5):HS1-HS6. ABSTRACT: Long-acting injectable (LAI) antipsychotics are an important treatment option to help improve adherence in patients with schizophrenia and schizoaffective disorder. LAI antipsychotics are managed and dosed differently than oral antipsychotics. Multiple LAI formulations have come to market in recent years, each with unique pharmacokinetics and drug characteristics.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →